Search
for
Sort by
Research 331–360 of 1000+
- Ancestral Diversity of Skin Reaches Single-Cell Resolution
- Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Alopecia areata
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Telogen hair loss
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Black Hairy Tongue Syndrome: Case Report and Review of the Literature
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Knowledge, Attitude, and Practice of Polycystic Ovarian Syndrome Diagnosis among Health Care Providers in Addis Ababa, Ethiopia
- Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- Immunological Abnormalities In PCOS
- Intranasal sensitization model of alopecia areata using pertussis toxin as adjuvant
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Repurposing DPP4-Inhibition to Improve Hair Follicle Activation and Regeneration
- The potential of regulatory T cell-based therapies for alopecia areata
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Entdeckung von Autoantigenen bei der Haarverluststörung Alopecia areata: Implikation von posttranslationalen Modifikationen
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Rare and Underappreciated Causes of Polycystic Ovarian Syndrome
- Areata-Like Lupus as a Clinical Manifestation of Cutaneous Lupus Erythematosus
- Cell death in the skin
- JAK Inhibitors for Treatment of Alopecia Areata